STERILLAB A/S

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  1.6% 0.9% 2.4% 0.9% 1.2%  
Credit score (0-100)  76 88 62 88 81  
Credit rating  A A BBB A A  
Credit limit (kDKK)  7.4 406.5 0.0 393.1 158.3  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  1,156 3,950 0.0 3,970 4,799  
EBITDA  -189 1,075 -315 998 1,796  
EBIT  -263 752 -857 722 1,101  
Pre-tax profit (PTP)  -25.9 756.3 -493.9 280.2 370.3  
Net earnings  -18.2 589.3 -386.0 280.2 370.3  
Pre-tax profit without non-rec. items  -25.9 756 -11.2 280 370  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  2,847 5,867 5,459 5,173 4,796  
Shareholders equity total  4,142 4,731 4,345 4,618 5,102  
Interest-bearing liabilities  2,716 4,791 5,471 5,893 1,856  
Balance sheet total (assets)  7,323 11,018 10,624 11,068 9,659  

Net Debt  567 2,361 3,181 3,304 -229  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  1,156 3,950 0.0 3,970 4,799  
Gross profit growth  -57.1% 241.7% -100.0% 0.0% 20.9%  
Employees  9 8 0 0 8  
Employee growth %  0.0% -11.1% -100.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  7,323 11,018 10,624 11,068 9,659  
Balance sheet change%  25.3% 50.5% -3.6% 4.2% -12.7%  
Added value  -189.1 1,075.1 -315.4 1,263.0 1,796.1  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -1,950 2,697 -949 -563 -1,072  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -2.0 1.0 -1.0 1.0 2.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  -22.7% 19.0% 0.0% 18.2% 22.9%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -0.4% 9.1% -0.1% 7.7% 10.6%  
ROI %  -0.4% 10.2% -0.1% 8.2% 12.6%  
ROE %  -0.4% 13.3% -8.5% 6.3% 7.6%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  56.6% 42.9% 40.9% 41.7% 52.8%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -299.7% 219.7% -1,008.7% 331.1% -12.7%  
Gearing %  65.6% 101.3% 125.9% 127.6% 36.4%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 2.1% 0.0% 9.8% 18.9%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  1.1 0.7 5.0 7.3 0.8  
Current Ratio  1.4 0.9 6.4 10.6 1.8  
Cash and cash equivalent  2,149.7 2,429.8 2,290.2 2,589.0 2,085.1  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -746.0 -2,350.5 2,311.7 3,296.3 122.6  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  -21 134 0 0 225  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  -21 134 0 0 225  
EBIT / employee  -29 94 0 0 138  
Net earnings / employee  -2 74 0 0 46